Healthcare

AMYLYX PHARMACEUTICALS INC

Ticker: AMLX

Exchange: US

Composite FIGI: BBG00DP10YT5

Total Alternative Signals

1signals tracked

Weighted Sentiment

+0.70weighted index

Avg Materiality Score

3.0/ 5.0 scale

Signal Distribution

1▲|0■|0▼

Alternative Data Signal Feed

Real-Time Ingestion Active

Unlock Alternative Signals Feed

Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for AMYLYX PHARMACEUTICALS INC. Programmatic API and Webhooks available.

Get Premium API Key How does alternative data signal modeling work?

Patent FilingBullish

Filing Date: 2026-06-22

Signal Event Report - FIGI BBG00DP10YT5

Amylyx Pharmaceuticals had a WIPO patent application for Chi3l1- published, indicating progress in protecting its intellectual property related to this compound.

Quantitative Investment Thesis

The publication of this patent strengthens Amylyx's intellectual property portfolio, potentially securing future revenue streams and reducing competition for its Chi3l1- related innovations, which is a positive long-term indicator for the company's market position.

Materiality & Sentiment Scores

Sentiment: 0.7

Materiality: 3 / 5

Source Document: https://patents.google.com/?assignee=AMYLYX%20PHARMACEUTICALS&sort=new